Media / Press

  • A global leader in hepatology, Mena manages 50% of all liver-related medical cases in California…

  • Latinos are the number one ethnic group in the U.S. with the highest prevalence of Hepatocellular Carcinoma (HCC)…

  • The Pasadena Liver Center provides patient-centered service by caring for the whole person…

  • Dr. Mena is a tireless advocate for the awareness of liver disease in the community…

Publications/Research

Democratizing Liver Assessment: A New Tool for Identifying MASLD/MASH at Any Point of Care.

Plasma Cell-Free DNA Methylation Markers for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Case-Control Study.

Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B Study

Emricasan to Prevent New Decompensation in Patients with NASH-Related Decompensated Cirrhosis.

Tropifexor plus Cenicriviroc Combination versus Monotherapy in Nonalcoholic Steatohepatitis: Results from the Phase 2b TANDEM Study

Diagnosis of Focal Nodular Hyperplasia (FNH) after Liver Transplantation.

Increased Accuracy in Identifying NAFLD with Advanced Fibrosis and Cirrhosis: Independent Validation of the Agile 3+ and 4 Scores.

Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis.

Participate in a Clinical Trial

Participating in clinical trials allows individuals to contribute to medical research while potentially accessing new treatments before they are widely available. By joining a trial, participants receive specialized care and monitoring from medical professionals. Engaging in clinical research not only helps advance medical knowledge but also has the potential to improve outcomes for future patients.